Dolphin Medical Services board to approve Kotha as chairman, Mallour reclassification
- Dolphin Medical Services Ltd holds board meeting on September 21, 2026
- Agenda includes appointing Amarandhar Reddy Kotha as Chairman and Promoter Director
- Rajesh Kumar Mallour to be reclassified from Professional to Promoter category
- Reconstitution of Board Committees planned following leadership changes
- Filings for Promoter Group reclassification subject to open offer compliances

*this image is generated using AI for illustrative purposes only.
Dolphin Medical Services Limited has scheduled a Board of Directors meeting for September 21, 2026, to consider significant changes in its leadership structure and promoter group composition. The session will focus on appointing Amarandhar Reddy Kotha as Chairman and Promoter Director, alongside the reclassification of Rajesh Kumar Mallour from Professional to Promoter category.
The company notified the Bombay Stock Exchange on September 20, 2026, pursuant to Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting is set to commence at 11:00 am.
Key Agenda Items
The Board will transact the following businesses during the scheduled session:
- Appointment of Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director, subject to applicable legal approvals.
- Change of category for Rajesh Kumar Mallour (DIN: 07425226) from Professional to Promoter, pending requisite approvals.
- Reconstitution of various Board Committees consequent to the proposed changes in Board composition.
- Authorization for Rajesh Kumar Mallour to make necessary intimations and filings with stock exchanges and regulatory authorities regarding the proposed reclassification of the Promoter/Promoter Group. This is contingent upon completion of applicable open offer compliances under SEBI LODR regulations.
Rajesh Kumar Mallour, Director (DIN: 08215774), signed the intimation letter on behalf of the company.
How might the appointment of Amarandhar Reddy Kotha as Chairman influence Dolphin Medical Services' strategic direction and market positioning?
What are the potential implications for minority shareholders if the open offer compliances under SEBI LODR regulations are triggered by this promoter group reclassification?
Could the reconstitution of Board Committees lead to changes in corporate governance practices or risk management frameworks at Dolphin Medical Services?
































